Thus, HIF1α activation of ACSS2 allows cancer cells to use acetate lipid synthesis in hypoxic conditions when oxidative production of acetyl-CoA may be limited (Comerford et al., 2014; Schug et al., 2015) (Fig. 2). Here, HIF1A is linked to cancer.